NHS England has agreed a deal with Vertex for its three-drug cystic fibrosis therapy Kaftrio, just days after the EMA’s human medicines committee recommended approval of the drug. The deal means that ...

Vertex Pharma has said it will use a priority review voucher (PRV) to speed up the FDA review of its new once-daily triple therapy for cystic fibrosis, which has just hit all its objectives in a pair ...

A tiny antibody component could fundamentally transform the treatment of cystic fibrosis: For the first time, researchers ...

A tiny antibody component could fundamentally transform the treatment of cystic fibrosis: For the first time, researchers ...

Comedian and "Bob's Burgers" voice actor Eugene Mirman is recovering after being involved in a flaming car crash. ( TMZ) ...

Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) announced the U.S. Food and Drug Administration (FDA) has approved expanded use of ALYFTREK® (vanzacaftor/tezacaftor/ivacaftor) for the treatment of ...

The agency has expanded the use of Alyftrek and Trikafta for treating patients with any genetic variant that results in production of CFTR proteins.

“Our findings highlight the need for further investigation into ETI’s role in bone health among pwCF [people with cystic fibrosis] and the need for ongoing attention to CFBD [cystic fibrosis bone ...

"For many families, the daily time commitment required for CF care can be overwhelming," Sagel said. "Seeing people maintain good health while doing fewer respiratory therapies is incredibly ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

In the US, nearly one third of eligible lung transplant recipients with cystic fibrosis (CF) received new elexacaftor-tezacaftor-ivacaftor (ETI) prescriptions post-transplant. The presence of sinus ...

Vertex Pharmaceuticals, a global biotechnology company that invests in scientific innovation to create transformative medicines for people with serious diseases and conditions, has announced that the ...